eNauka - pregled
Pregled prema Autor Andreas, A. P.
Prikaz rezultata 1 do 1 od 1
| Godina | Naslov | Autor(i) | Tip rezultata | Mp-kat. |
|---|---|---|---|---|
| 2008 | High doses of imatinib mesylate (800 mg/day) significantly improve rates of major and complete cytogenetic remissions (mcr, ccr) - results from the first planned interim analysis of a multicenter, randomised, 2-arm - phase III study comparing imatinib standard dose (400 mg/day) with imatinib high do | Andreas, A. P.; Bošković, Darinka; Lejniece, S. | Konferencijski rad | Mp kategorija će biti prikazana naknadno. |